메뉴 건너뛰기




Volumn 2, Issue , 2010, Pages 133-156

Recent advances in basic and clinical aspects in inflammatory bowel diseases, as crohn’s disease and ulcerative colitis: Role of gastrointestinal granulocytes

Author keywords

[No Author keywords available]

Indexed keywords


EID: 85017079804     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter
Times cited : (5)

References (154)
  • 2
    • 0037043658 scopus 로고    scopus 로고
    • Inflammatory bowel disease
    • Podolsky, DK. Inflammatory bowel disease. N Engl J Med, 2002, 347, 417-429.
    • (2002) N Engl J Med , vol.347 , pp. 417-429
    • Podolsky, D.K.1
  • 3
    • 0024404284 scopus 로고
    • Dietary antigens as aggravating factors in Crohn’s disease
    • Harris, ML; Bayless, TM. Dietary antigens as aggravating factors in Crohn’s disease. Dig Dis Sci, 1989, 34, 1613-1614.
    • (1989) Dig Dis Sci , vol.34 , pp. 1613-1614
    • Harris, M.L.1    Bayless, T.M.2
  • 4
    • 0021894149 scopus 로고
    • Inflammatory bowel disease at the University of Chicago-the first 50 years: Some personal reflections
    • Kirsner, JB. Inflammatory bowel disease at the University of Chicago-the first 50 years: some personal reflections. Am J Gastroenterol, 1985, 80, 219-226.
    • (1985) Am J Gastroenterol , vol.80 , pp. 219-226
    • Kirsner, J.B.1
  • 7
    • 33750609696 scopus 로고    scopus 로고
    • Recent trends in the epidemiology of inflammatory bowel diseases: Up or down?
    • Lakatos, PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol, 2006, 12, 6102-6108.
    • (2006) World J Gastroenterol , vol.12 , pp. 6102-6108
    • Lakatos, P.L.1
  • 9
    • 0037022008 scopus 로고    scopus 로고
    • Crohn’s disease
    • Shanahan, F. Crohn’s disease. Lancet, 2002, 359, 62-69.
    • (2002) Lancet , vol.359 , pp. 62-69
    • Shanahan, F.1
  • 11
    • 33644826707 scopus 로고    scopus 로고
    • Crohn’s disease in mainland China: A systematic analysis of 50 years of research
    • Zheng, JJ; Zhu, XS; Huangfu, Z; Gao, ZX; Guo, ZR; Wang, Z. Crohn’s disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis, 2005, 6, 175-181.
    • (2005) Chin J Dig Dis , vol.6 , pp. 175-181
    • Zheng, J.J.1    Zhu, X.S.2    Huangfu, Z.3    Gao, Z.X.4    Guo, Z.R.5    Wang, Z.6
  • 12
    • 34249827613 scopus 로고    scopus 로고
    • Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?
    • Asakura, H; Suzuki, K; Honma, T. Recent advances in basic and clinical aspects of inflammatory bowel disease: Which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?. World J Gastroenterol, 2007, 13, 2145-2149.
    • (2007) World J Gastroenterol , vol.13 , pp. 2145-2149
    • Asakura, H.1    Suzuki, K.2    Honma, T.3
  • 13
    • 0030830553 scopus 로고    scopus 로고
    • Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases
    • Sartor, RB. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol, 1997, 92, 5S-11S.
    • (1997) Am J Gastroenterol , vol.92 , pp. 5S-11S
    • Sartor, R.B.1
  • 14
    • 0020964483 scopus 로고
    • Sulfasalazine. Adverse effects and desensitization
    • Taffet, SL; Das, KM. Sulfasalazine. Adverse effects and desensitization. Dig Dis Sci, 1983, 28, 833-842.
    • (1983) Dig Dis Sci , vol.28 , pp. 833-842
    • Taffet, S.L.1    Das, K.M.2
  • 15
    • 0034132356 scopus 로고    scopus 로고
    • How to do without steroids in inflammatory bowel disease
    • Present, DH. How to do without steroids in inflammatory bowel disease. Inflamm Bowel Dis, 2000, 6, 48-57.
    • (2000) Inflamm Bowel Dis , vol.6 , pp. 48-57
    • Present, D.H.1
  • 16
    • 0024587677 scopus 로고
    • Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomised trial
    • Rachmilewitz, D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ, 1989, 298, 82-86.
    • (1989) BMJ , vol.298 , pp. 82-86
    • Rachmilewitz, D.1
  • 17
    • 2442526434 scopus 로고    scopus 로고
    • Medical therapy for ulcerative colitis 2004
    • Hanauer, SB. Medical therapy for ulcerative colitis 2004. Gastroenterology, 2004, 126, 1582-1592.
    • (2004) Gastroenterology , vol.126 , pp. 1582-1592
    • Hanauer, S.B.1
  • 18
    • 0029013896 scopus 로고
    • How effective is current medical therapy for severe ulcerative and Crohn’s colitis? An analytic review of selected trials
    • Kornbluth, A; Marion, JF; Salomon, P; Janowitz, HD. How effective is current medical therapy for severe ulcerative and Crohn’s colitis? An analytic review of selected trials. J Clin Gastroenterol, 1995, 20, 280-284.
    • (1995) J Clin Gastroenterol , vol.20 , pp. 280-284
    • Kornbluth, A.1    Marion, J.F.2    Salomon, P.3    Janowitz, H.D.4
  • 19
    • 0031776748 scopus 로고    scopus 로고
    • Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: Time for a reappraisal?
    • Hyde, GM; Thillainayagam, AV; Jewell DP. Intravenous cyclosporin as rescue therapy in severe ulcerative colitis: time for a reappraisal? Eur J Gastroenterol Hepatol, 1998, 10, 411-413.
    • (1998) Eur J Gastroenterol Hepatol , vol.10 , pp. 411-413
    • Hyde, G.M.1    Thillainayagam, A.V.2    Jewell, D.P.3
  • 20
    • 1842689546 scopus 로고    scopus 로고
    • Can cyclosporine go it alone in severe ulcerative colitis?
    • Hanauer, SB. Can cyclosporine go it alone in severe ulcerative colitis? Curr Gastroenterol Rep, 2001, 3, 455-456.
    • (2001) Curr Gastroenterol Rep , vol.3 , pp. 455-456
    • Hanauer, S.B.1
  • 21
    • 2342560435 scopus 로고    scopus 로고
    • Biochemical mechanisms of cyclosporine neurotoxicity
    • Serkova, NJ; Christians, U; Benet, LZ. Biochemical mechanisms of cyclosporine neurotoxicity. Mol Interv, 2004, 4, 97-107.
    • (2004) Mol Interv , vol.4 , pp. 97-107
    • Serkova, N.J.1    Christians, U.2    Benet, L.Z.3
  • 23
    • 0034005581 scopus 로고    scopus 로고
    • Role of cytokines in the pathogenesis of inflammatory bowel disease
    • Papadakis, KA; Targan, SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med, 2000, 51, 289-298.
    • (2000) Annu Rev Med , vol.51 , pp. 289-298
    • Papadakis, K.A.1    Targan, S.R.2
  • 27
    • 20444487429 scopus 로고    scopus 로고
    • Infliximab induction and maintenance therapy for ulcerative colitis: The ACT2 trial
    • Sandborn, WJ; Rachmilewitz, D; Hanauer, SB. Infliximab induction and maintenance therapy for ulcerative colitis: the ACT2 trial. Gastroenterology, 2005, 128, A36.
    • (2005) Gastroenterology , vol.128 , pp. A36
    • Sandborn, W.J.1    Rachmilewitz, D.2    Hanauer, S.B.3
  • 28
    • 0037640033 scopus 로고    scopus 로고
    • Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy
    • Devos, SA; Van Den Bossche, N; De Vos, M; Naeyaert, JM. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology, 2003, 206, 388-390.
    • (2003) Dermatology , vol.206 , pp. 388-390
    • Devos, S.A.1    Van Den Bossche, N.2    De Vos, M.3    Naeyaert, J.M.4
  • 29
    • 0036272256 scopus 로고    scopus 로고
    • Review article: A critical approach to new forms of treatment of Crohn’s disease and ulcerative colitis
    • Seegers, D; Bouma, G; Pena, AS. Review article: a critical approach to new forms of treatment of Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther, 2002, 16 Suppl, 4, 53-58.
    • (2002) Aliment Pharmacol Ther , vol.4 , Issue.16 , pp. 53-58
    • Seegers, D.1    Bouma, G.2    Pena, A.S.3
  • 30
    • 0041653315 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report
    • Gomez-Reino, JJ; Carmona, L; Valverde, VR; Mola, EM; Montero, MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum, 2003, 48, 2122-2127.
    • (2003) Arthritis Rheum , vol.48 , pp. 2122-2127
    • Gomez-Reino, J.J.1    Carmona, L.2    Valverde, V.R.3    Mola, E.M.4    Montero, M.D.5
  • 31
    • 0042027086 scopus 로고    scopus 로고
    • Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy
    • (Oxford)
    • Kroesen, S; Widmer, AF; Tyndall, A; Hasler P. Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford), 2003, 42, 617-621.
    • (2003) Rheumatology , vol.42 , pp. 617-621
    • Kroesen, S.1    Widmer, A.F.2    Tyndall, A.3    Hasler, P.4
  • 32
    • 0036900501 scopus 로고    scopus 로고
    • Tumor necrosis factor antagonist therapy and lymphoma development, twenty-six cases reported to the Food and Drug Administration
    • Brown, SL; Greene, MH; Gershon, SK; Edwards, ET; Braun, MM. Tumor necrosis factor antagonist therapy and lymphoma development, twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum, 2002, 46, 3151-3158.
    • (2002) Arthritis Rheum , vol.46 , pp. 3151-3158
    • Brown, S.L.1    Greene, M.H.2    Gershon, S.K.3    Edwards, E.T.4    Braun, M.M.5
  • 34
    • 33646696885 scopus 로고    scopus 로고
    • Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
    • Bongartz, T; Sutton, AJ; Sweeting, MJ; Buchan, I; Matteson, EL; Montori, V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA, 2006, 295, 2275-2285.
    • (2006) JAMA , vol.295 , pp. 2275-2285
    • Bongartz, T.1    Sutton, A.J.2    Sweeting, M.J.3    Buchan, I.4    Matteson, E.L.5    Montori, V.6
  • 35
    • 33747143080 scopus 로고    scopus 로고
    • Anorectal carcinoma after infliximab therapy in Crohn’s disease: Report of a case
    • Melichar, B; Bures, J; Dedic, K. Anorectal carcinoma after infliximab therapy in Crohn’s disease: report of a case. Dis Colon Rectum, 2006, 49, 1228-1233.
    • (2006) Dis Colon Rectum , vol.49 , pp. 1228-1233
    • Melichar, B.1    Bures, J.2    Dedic, K.3
  • 36
    • 0028894398 scopus 로고
    • The production of cytokines by polymorphonuclear neutrophils
    • Cassatella, MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today, 1995, 16, 21-26.
    • (1995) Immunol Today , vol.16 , pp. 21-26
    • Cassatella, M.A.1
  • 37
    • 0031903013 scopus 로고    scopus 로고
    • Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation
    • Nikolaus, S; Bauditz, J; Gionchetti, P; Witt, C; Lochs, H; Schreiber, S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut, 1998, 42, 470-476.
    • (1998) Gut , vol.42 , pp. 470-476
    • Nikolaus, S.1    Bauditz, J.2    Gionchetti, P.3    Witt, C.4    Lochs, H.5    Schreiber, S.6
  • 41
    • 37849049256 scopus 로고    scopus 로고
    • CCL5/RANTES chemokine polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population
    • Muro, M; Marin, L; Torio, A; Pagan, JA; Álvarez-López, MR. CCL5/RANTES chemokine polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Int J Immunogenetics, 2008, 35, 19-23.
    • (2008) Int J Immunogenetics , vol.35 , pp. 19-23
    • Muro, M.1    Marin, L.2    Torio, A.3    Pagan, J.A.4
  • 42
    • 0034234796 scopus 로고    scopus 로고
    • Surrogate markers of intestinal infl ammation are predictive of relapse in patients with inflammatory bowel disease
    • Tibble, JA; Sigthorsson, G; Bridger, S; Fagerhol, MK; Bjarnason, I. Surrogate markers of intestinal infl ammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology, 2000, 119, 15-22.
    • (2000) Gastroenterology , vol.119 , pp. 15-22
    • Tibble, J.A.1    Sigthorsson, G.2    Bridger, S.3    Fagerhol, M.K.4    Bjarnason, I.5
  • 44
    • 0033013167 scopus 로고    scopus 로고
    • Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease
    • Roseth, AG; Schmidt, PN; Fagerhol, MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol, 1999, 34, 50-54.
    • (1999) Scand J Gastroenterol , vol.34 , pp. 50-54
    • Roseth, A.G.1    Schmidt, P.N.2    Fagerhol, M.K.3
  • 45
    • 0025721860 scopus 로고
    • Peripheral blood neutrophils in inflammatory bowel disease: Morphological evidence of in vivo activation in active disease
    • McCarthy, DA; Rampton, DS; Liu, YC. Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol, 1991, 86, 489-493.
    • (1991) Clin Exp Immunol , vol.86 , pp. 489-493
    • McCarthy, D.A.1    Rampton, D.S.2    Liu, Y.C.3
  • 46
    • 0034133163 scopus 로고    scopus 로고
    • The key role of macrophages in the immunopathogenesis of inflammatory bowel disease
    • Mahida, YR. The key role of macrophages in the immunopathogenesis of inflammatory bowel disease. Inflamm Bowel Dis, 2000, 6, 21-33.
    • (2000) Inflamm Bowel Dis , vol.6 , pp. 21-33
    • Mahida, Y.R.1
  • 47
    • 0036797131 scopus 로고    scopus 로고
    • Therapeutic effi cacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis
    • Hanai, H; Watanabe, F; Saniabadi, AR; Matsushitai, I; Takeuchi, K; Iida, T. Therapeutic effi cacy of granulocyte and monocyte adsorption apheresis in severe active ulcerative colitis. Dig Dis Sci, 2002, 47, 2349-2353.
    • (2002) Dig Dis Sci , vol.47 , pp. 2349-2353
    • Hanai, H.1    Watanabe, F.2    Saniabadi, A.R.3    Matsushitai, I.4    Takeuchi, K.5    Iida, T.6
  • 49
    • 0038779569 scopus 로고    scopus 로고
    • Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes
    • Saniabadi, AR; Hanai, H; Takeuchi, K; Umemura, K; Nakashima, M; Adachi, T, Shima, C; Bjarnason, I; Lofberg, R. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial, 2003, 7, 48-59.
    • (2003) Ther Apher Dial , vol.7 , pp. 48-59
    • Saniabadi, A.R.1    Hanai, H.2    Takeuchi, K.3    Umemura, K.4    Nakashima, M.5    Adachi, T.6    Shima, C.7    Bjarnason, I.8    Lofberg, R.9
  • 50
    • 0028240846 scopus 로고
    • Increased macrophage subset in inflammatory bowel disease: Apparent recruitment from peripheral blood monocytes
    • Rugtveit, J; Brandtzaeg, P; Halstensen, TS; Fausa, O; Scott, H. Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes. Gut, 1994, 35, 669-674.
    • (1994) Gut , vol.35 , pp. 669-674
    • Rugtveit, J.1    Brandtzaeg, P.2    Halstensen, T.S.3    Fausa, O.4    Scott, H.5
  • 51
    • 0018140011 scopus 로고
    • Macrophage turnover in Crohn’s disease and ulcerative colitis
    • Meuret, G; Bitzi, A; Hammer, B. Macrophage turnover in Crohn’s disease and ulcerative colitis. Gastroenterology, 1978, 74, 501-503.
    • (1978) Gastroenterology , vol.74 , pp. 501-503
    • Meuret, G.1    Bitzi, A.2    Hammer, B.3
  • 53
    • 0029972142 scopus 로고    scopus 로고
    • Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes
    • Meagher, LC; Cousin, JM; Seckl, JR; Haslett, C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol, 1996,156, 4422-4428.
    • (1996) J Immunol , vol.156 , pp. 4422-4428
    • Meagher, L.C.1    Cousin, J.M.2    Seckl, J.R.3    Haslett, C.4
  • 54
    • 0027484754 scopus 로고
    • Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators
    • Lee, A; Whyte, MK; Haslett, C. Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol, 1993, 54, 283-288.
    • (1993) J Leukoc Biol , vol.54 , pp. 283-288
    • Lee, A.1    Whyte, M.K.2    Haslett, C.3
  • 55
    • 23344431535 scopus 로고    scopus 로고
    • Defects in mucosal immunity leading to Crohn’s disease
    • Cobrin, GM; Abreu, MT. Defects in mucosal immunity leading to Crohn’s disease. Immunol Rev, 2005, 206, 277-295.
    • (2005) Immunol Rev , vol.206 , pp. 277-295
    • Cobrin, G.M.1    Abreu, M.T.2
  • 57
    • 0142249896 scopus 로고    scopus 로고
    • Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology
    • Timmer, A. Environmental influences on inflammatory bowel disease manifestations. Lessons from epidemiology. Dig Dis, 2003, 21, 91-104.
    • (2003) Dig Dis , vol.21 , pp. 91-104
    • Timmer, A.1
  • 58
    • 0041927822 scopus 로고    scopus 로고
    • Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning
    • Zheng, CQ; Hu, GZ; Zeng, ZS; Lin, LJ; Gu, GG. Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning. World J Gastroenterol, 2003, 9, 1646-1656.
    • (2003) World J Gastroenterol , vol.9 , pp. 1646-1656
    • Zheng, C.Q.1    Hu, G.Z.2    Zeng, Z.S.3    Lin, L.J.4    Gu, G.G.5
  • 59
    • 21844432979 scopus 로고    scopus 로고
    • Nucleotide-binding-oligomerization domain proteins and toll-like receptors: Sensors of the inflammatory bowel diseases’ microbial environment
    • Mueller, T; Podolsky, DK. Nucleotide-binding-oligomerization domain proteins and toll-like receptors: sensors of the inflammatory bowel diseases’ microbial environment. Curr Opin Gastroenterol, 2005, 21, 419-425.
    • (2005) Curr Opin Gastroenterol , vol.21 , pp. 419-425
    • Mueller, T.1    Podolsky, D.K.2
  • 64
    • 33750228901 scopus 로고    scopus 로고
    • Probiotics and prebiotics in chronic inflammatory bowel diseases
    • Ewaschuk, JB; Dieleman, LA. Probiotics and prebiotics in chronic inflammatory bowel diseases. World J Gastroenterol, 2006, 12, 5941-5950.
    • (2006) World J Gastroenterol , vol.12 , pp. 5941-5950
    • Ewaschuk, J.B.1    Dieleman, L.A.2
  • 66
    • 27744437941 scopus 로고    scopus 로고
    • Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria
    • Kamada, N; Hisamatsu, T; Okamoto, S; Sato, T; Matsuoka, K; Arai, K; Nakai, T; Hasegawa, A; Inoue, N; Watanabe, N; Akagawa, KS; Hibi, T. Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol, 2005, 175, 6900-6908.
    • (2005) J Immunol , vol.175 , pp. 6900-6908
    • Kamada, N.1    Hisamatsu, T.2    Okamoto, S.3    Sato, T.4    Matsuoka, K.5    Arai, K.6    Nakai, T.7    Hasegawa, A.8    Inoue, N.9    Watanabe, N.10    Akagawa, K.S.11    Hibi, T.12
  • 67
    • 23344446340 scopus 로고    scopus 로고
    • Defects in mucosal immunity leading to ulcerative colitis
    • Targan, SR; Karp, LC. Defects in mucosal immunity leading to ulcerative colitis. Immunol Rev, 2005, 206, 296-305.
    • (2005) Immunol Rev , vol.206 , pp. 296-305
    • Targan, S.R.1    Karp, L.C.2
  • 78
    • 33645824349 scopus 로고    scopus 로고
    • Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L-effector memory T cells
    • Kanai, T; Tanimoto, K; Nemoto, Y; Fujii, R; Makita, S; Totsuka, T; Watanabe, M. Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L-effector memory T cells. Am J Physiol Gastrointest Liver Physiol, 2006, 290, G1051-G1058.
    • (2006) Am J Physiol Gastrointest Liver Physiol , vol.290 , pp. G1051-G1058
    • Kanai, T.1    Tanimoto, K.2    Nemoto, Y.3    Fujii, R.4    Makita, S.5    Totsuka, T.6    Watanabe, M.7
  • 79
    • 33745275219 scopus 로고    scopus 로고
    • Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity
    • Holmen, N; Lundgren, A; Lundin, S; Bergin, AM; Rudin, A; Sjovall, H; Ohman, L. Functional CD4+CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity. Inflamm Bowel Dis, 2006, 12, 447-456.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 447-456
    • Holmen, N.1    Lundgren, A.2    Lundin, S.3    Bergin, A.M.4    Rudin, A.5    Sjovall, H.6    Ohman, L.7
  • 80
    • 17844363998 scopus 로고    scopus 로고
    • Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease
    • Brimnes, J; Allez, M; Dotan, I; Shao, L; Nakazawa, A; Mayer, L. Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J Immunol, 2005, 174, 5814-5822.
    • (2005) J Immunol , vol.174 , pp. 5814-5822
    • Brimnes, J.1    Allez, M.2    Dotan, I.3    Shao, L.4    Nakazawa, A.5    Mayer, L.6
  • 89
    • 0025819520 scopus 로고
    • Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease
    • Miura, S; Yoshioka, M; Tanaka, S; Serizawa, H; Tashiro, H; Asakura, H; Tsuchiya, M. Faecal clearance of alpha 1-antitrypsin reflects disease activity and correlates with rapid turnover proteins in chronic inflammatory bowel disease. J Gastroenterol Hepatol 1991, 6, 49-52.
    • (1991) J Gastroenterol Hepatol , vol.6 , pp. 49-52
    • Miura, S.1    Yoshioka, M.2    Tanaka, S.3    Serizawa, H.4    Tashiro, H.5    Asakura, H.6    Tsuchiya, M.7
  • 94
    • 0027180157 scopus 로고
    • Increased fecal eosinophil cationic protein in inflammatory bowel disease
    • Berstad, A; Borkje, B; Riedel, B, et al. Increased fecal eosinophil cationic protein in inflammatory bowel disease. Hepato-Gastroenterol, 1993, 40, 276-278.
    • (1993) Hepato-Gastroenterol , vol.40 , pp. 276-278
    • Berstad, A.1    Borkje, B.2    Riedel, B.3
  • 95
    • 0031409459 scopus 로고    scopus 로고
    • Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease
    • Levy, AM; Gleich, GJ; Sandborn, WJ, et al. Increased eosinophil granule proteins in gut lavage fluid from patients with inflammatory bowel disease. Mayo Clin Proc, 1997, 72, 117-123.
    • (1997) Mayo Clin Proc , vol.72 , pp. 117-123
    • Levy, A.M.1    Gleich, G.J.2    Sandborn, W.J.3
  • 96
    • 0031895124 scopus 로고    scopus 로고
    • Eosinophil activation in ulcerative colitis. Studies on mucosal release and localization of eosinophil granule constituents
    • Raab, Y; Fredens, K; Gerdin, B, et al. Eosinophil activation in ulcerative colitis. Studies on mucosal release and localization of eosinophil granule constituents. Dig Dis Sci, 1998, 43, 1061-1070.
    • (1998) Dig Dis Sci , vol.43 , pp. 1061-1070
    • Raab, Y.1    Fredens, K.2    Gerdin, B.3
  • 98
    • 43549120052 scopus 로고    scopus 로고
    • Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours
    • Wedemeyer, J; Vosskuhl, K. Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours. Best Pract Res Clin Gastroenterol, 2008, 22, 537-549.
    • (2008) Best Pract Res Clin Gastroenterol , vol.22 , pp. 537-549
    • Wedemeyer, J.1    Vosskuhl, K.2
  • 100
    • 0028943866 scopus 로고
    • Human neutrophil Fc receptor-mediated adhesion under flow: A hollow fibre model of intravascular arrest
    • D’Arrigo, C; Candal-Couto, JJ; Greer, M; Veale, DJ; Woof, JM. Human neutrophil Fc receptor-mediated adhesion under flow: a hollow fibre model of intravascular arrest. Clin Exp Immunol, 1995, 100, 173-179.
    • (1995) Clin Exp Immunol , vol.100 , pp. 173-179
    • D’Arrigo, C.1    Candal-Couto, J.J.2    Greer, M.3    Veale, D.J.4    Woof, J.M.5
  • 101
    • 0037810900 scopus 로고    scopus 로고
    • Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: An in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis
    • Hiraishi, K; Takeda, Y; Shiobara, N; Shibusawa, H; Jimma, F; Kashiwagi, N; Saniabadi, AR; Adachi, M. Studies on the mechanisms of leukocyte adhesion to cellulose acetate beads: an in vitro model to assess the efficacy of cellulose acetate carrier-based granulocyte and monocyte adsorptive apheresis. Ther Apher Dial, 2003, 7, 334-340.
    • (2003) Ther Apher Dial , vol.7 , pp. 334-340
    • Hiraishi, K.1    Takeda, Y.2    Shiobara, N.3    Shibusawa, H.4    Jimma, F.5    Kashiwagi, N.6    Saniabadi, A.R.7    Adachi, M.8
  • 102
    • 2942741259 scopus 로고    scopus 로고
    • Selective granulocyte and monocyte adsorptive apheresis as a first line treatment for steroid naive patients with active ulcerative colitis: A prospective uncontrolled study
    • Suzuki, Y; Yoshimura, N; Saniabadi, AR; Saito, Y. Selective granulocyte and monocyte adsorptive apheresis as a first line treatment for steroid naive patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci, 2004, 49, 565-571.
    • (2004) Dig Dis Sci , vol.49 , pp. 565-571
    • Suzuki, Y.1    Yoshimura, N.2    Saniabadi, A.R.3    Saito, Y.4
  • 103
    • 11144304095 scopus 로고    scopus 로고
    • Treating ulcerative colitis without medications-“look mom, no drugs!"
    • Cohen, RD. Treating ulcerative colitis without medications-“look mom, no drugs!". Gastroenterology, 2005, 128, 235-236.
    • (2005) Gastroenterology , vol.128 , pp. 235-236
    • Cohen, R.D.1
  • 104
    • 30544454919 scopus 로고    scopus 로고
    • Evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis
    • Kanke, K; Nakano, M; Hiraishi, H; Terano, A. Evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis. Dig Liv Dis, 2004, 36, 512-518.
    • (2004) Dig Liv Dis , vol.36 , pp. 512-518
    • Kanke, K.1    Nakano, M.2    Hiraishi, H.3    Terano, A.4
  • 105
    • 2442576094 scopus 로고    scopus 로고
    • Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or-dependent ulcerative colitis
    • Naganuma, M; Funakoshi, S; Sakuraba, A; Takagi, H; Inoue, N; Ogata, H; Iwao, Y; Ishi, H; Hibi, T. Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or-dependent ulcerative colitis. Inflamm Bowel Dis, 2004, 10, 251-257.
    • (2004) Inflamm Bowel Dis , vol.10 , pp. 251-257
    • Naganuma, M.1    Funakoshi, S.2    Sakuraba, A.3    Takagi, H.4    Inoue, N.5    Ogata, H.6    Iwao, Y.7    Ishi, H.8    Hibi, T.9
  • 107
    • 4444299017 scopus 로고    scopus 로고
    • Granulocyte, macrophage, monocyte apheresis for refractory ulcerative proctitis
    • Premchand, P; Takeuchi, K; Bjarnason, I. Granulocyte, macrophage, monocyte apheresis for refractory ulcerative proctitis. Eur J Gastroenterol Hepatol, 2004, 16, 943-945.
    • (2004) Eur J Gastroenterol Hepatol , vol.16 , pp. 943-945
    • Premchand, P.1    Takeuchi, K.2    Bjarnason, I.3
  • 109
    • 0037285976 scopus 로고    scopus 로고
    • Granulocytapheresis for Crohn’s disease: A report on seven refractory patients
    • Matsui, T; Nishimura, T; Matake, H; Ohta, T; Sakurai, T; Yao, T. Granulocytapheresis for Crohn’s disease: a report on seven refractory patients. Am J Gastroenterol, 2003, 98, 511-512.
    • (2003) Am J Gastroenterol , vol.98 , pp. 511-512
    • Matsui, T.1    Nishimura, T.2    Matake, H.3    Ohta, T.4    Sakurai, T.5    Yao, T.6
  • 113
    • 33751538077 scopus 로고    scopus 로고
    • A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis
    • Suzuki, Y; Yoshimura, N; Saito, Y; Saniabadi, A. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci, 2006, 51, 2031-2038.
    • (2006) Dig Dis Sci , vol.51 , pp. 2031-2038
    • Suzuki, Y.1    Yoshimura, N.2    Saito, Y.3    Saniabadi, A.4
  • 114
    • 33845971251 scopus 로고    scopus 로고
    • Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis
    • Hanai, H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol, 2006, 12, 7568-7577.
    • (2006) World J Gastroenterol , vol.12 , pp. 7568-7577
    • Hanai, H.1
  • 116
    • 33646540632 scopus 로고    scopus 로고
    • Adacolumn apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse (abstract)
    • Maiden, L; Baur, R; Takeuchi, K; Bjarnason, I. Adacolumn apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse (abstract). Gut, 2005, 54 (suppl NOVII): A57.
    • (2005) Gut , vol.54 , pp. A57
    • Maiden, L.1    Baur, R.2    Takeuchi, K.3    Bjarnason, I.4
  • 117
    • 0031903013 scopus 로고    scopus 로고
    • Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation
    • Nikolaus, S; Bauditz, J; Gionchetti, P; Witt, C; Lochs, H; Schreiber, S. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation. Gut, 1998, 42, 470-476.
    • (1998) Gut , vol.42 , pp. 470-476
    • Nikolaus, S.1    Bauditz, J.2    Gionchetti, P.3    Witt, C.4    Lochs, H.5    Schreiber, S.6
  • 118
    • 0034234796 scopus 로고    scopus 로고
    • Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
    • Tibble, JA; Sigthorsson, G; Bridger, S; Fagerhol, MK; Bjarnason, I. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology, 2000, 119, 15-22.
    • (2000) Gastroenterology , vol.119 , pp. 15-22
    • Tibble, J.A.1    Sigthorsson, G.2    Bridger, S.3    Fagerhol, M.K.4    Bjarnason, I.5
  • 120
    • 0033013167 scopus 로고    scopus 로고
    • Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease
    • Roseth, AG; Schmidt, PN; Fagerhol, MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol, 1999, 34, 50-54.
    • (1999) Scand J Gastroenterol , vol.34 , pp. 50-54
    • Roseth, A.G.1    Schmidt, P.N.2    Fagerhol, M.K.3
  • 121
    • 0028894398 scopus 로고
    • The production of cytokines by polymorphonuclear neutrophils
    • Cassatella, MA. The production of cytokines by polymorphonuclear neutrophils. Immunol Today, 1995, 16, 21-26.
    • (1995) Immunol Today , vol.16 , pp. 21-26
    • Cassatella, M.A.1
  • 122
    • 33747399413 scopus 로고    scopus 로고
    • Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: Cytokine profiles and endoscopic findings
    • Yamamoto, T; Saniabadi, AR; Umegae, S; Matsumoto, K. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: cytokine profiles and endoscopic findings. Inflamm Bowel Dis, 2006, 12, 719-726.
    • (2006) Inflamm Bowel Dis , vol.12 , pp. 719-726
    • Yamamoto, T.1    Saniabadi, A.R.2    Umegae, S.3    Matsumoto, K.4
  • 124
    • 33646571241 scopus 로고    scopus 로고
    • The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease
    • Kanai, T; Hibi, T; Watanabe, M. The logics of leukocytapheresis as a natural biological therapy for inflammatory bowel disease. Expert Opin Biol Ther, 2006, 6, 453-466.
    • (2006) Expert Opin Biol Ther , vol.6 , pp. 453-466
    • Kanai, T.1    Hibi, T.2    Watanabe, M.3
  • 126
    • 0027198002 scopus 로고
    • Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
    • Mohler, KM; Torrance, DS; Smith, CA; Goodwin, RG; Stremler, KE, Fung, VP; Madani, H; Widmer, MB. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol, 1993, 151, 1548-1561.
    • (1993) J Immunol , vol.151 , pp. 1548-1561
    • Mohler, K.M.1    Torrance, D.S.2    Smith, C.A.3    Goodwin, R.G.4    Stremler, K.E.5    Fung, V.P.6    Madani, H.7    Widmer, M.B.8
  • 127
    • 0031835846 scopus 로고    scopus 로고
    • A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis
    • Kashiwagi, N; Hirata, I; Kasukawa, R. A role for granulocyte and monocyte apheresis in the treatment of rheumatoid arthritis. Ther Apher, 1998, 2, 134-141.
    • (1998) Ther Apher , vol.2 , pp. 134-141
    • Kashiwagi, N.1    Hirata, I.2    Kasukawa, R.3
  • 128
    • 0036270464 scopus 로고    scopus 로고
    • Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis
    • Kashiwagi, N; Sugimura, K; Koiwai, H; Yamamoto, H; Yoshikawa, T; Saniabadi, AR; Adachi, M; Shimoyama, T. Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci, 2002, 47, 1334-1341.
    • (2002) Dig Dis Sci , vol.47 , pp. 1334-1341
    • Kashiwagi, N.1    Sugimura, K.2    Koiwai, H.3    Yamamoto, H.4    Yoshikawa, T.5    Saniabadi, A.R.6    Adachi, M.7    Shimoyama, T.8
  • 129
    • 3242745879 scopus 로고    scopus 로고
    • Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: Evidence for the involvement of plasma IgG, complement C3 and beta2 integrin
    • Takeda, Y; Shiobara, N; Saniabadi, AR; Adachi, M; Hiraishi, K. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: evidence for the involvement of plasma IgG, complement C3 and beta2 integrin. Inflamm Res, 2004, 53, 277-283.
    • (2004) Inflamm Res , vol.53 , pp. 277-283
    • Takeda, Y.1    Shiobara, N.2    Saniabadi, A.R.3    Adachi, M.4    Hiraishi, K.5
  • 130
    • 0031861940 scopus 로고    scopus 로고
    • Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD)
    • Dionne, S; D’Agata, ID; Hiscott, J; Vanounou, T; Seidman, EG. Colonic explant production of IL-1and its receptor antagonist is imbalanced in inflammatory bowel disease (IBD). Clin Exp Immunol, 1998, 112, 435-442.
    • (1998) Clin Exp Immunol , vol.112 , pp. 435-442
    • Dionne, S.1    D’Agata, I.D.2    Hiscott, J.3    Vanounou, T.4    Seidman, E.G.5
  • 131
    • 0026056197 scopus 로고
    • Blocking IL-1: Interleukin 1 receptor antagonist in vivo and in vitro
    • Dinarello, CA; Thompson, RC. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today, 1991, 12, 404-410.
    • (1991) Immunol Today , vol.12 , pp. 404-410
    • Dinarello, C.A.1    Thompson, R.C.2
  • 133
    • 62149090337 scopus 로고    scopus 로고
    • Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy
    • Hanai, H. Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy. Eur J Gastroenterol Hepatol, 2008, 20, 596-600.
    • (2008) Eur J Gastroenterol Hepatol , vol.20 , pp. 596-600
    • Hanai, H.1
  • 134
    • 31844441031 scopus 로고    scopus 로고
    • Serologic Markers in Inflammatory Bowel Disease
    • Bossuit, X. Serologic Markers in Inflammatory Bowel Disease. Clin Chemistry, 2006, 52, 171-181.
    • (2006) Clin Chemistry , vol.52 , pp. 171-181
    • Bossuit, X.1
  • 135
    • 34249863151 scopus 로고    scopus 로고
    • Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicenter study
    • Desplat-Jégo, S; Johanet, C; Escande, A; Goetz, J; Fabien, N; Olsson, N; Ballot, E; Sarles, J; Baudon, JJ; Grimaud, JC; Veyrac, M; Chamouard, P; Humbel, RL. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: Results of a multicenter study. World J Gastroenterol, 2007, 13, 2312-2318.
    • (2007) World J Gastroenterol , vol.13 , pp. 2312-2318
    • Desplat-Jégo, S.1    Johanet, C.2    Escande, A.3    Goetz, J.4    Fabien, N.5    Olsson, N.6    Ballot, E.7    Sarles, J.8    Baudon, J.J.9    Grimaud, J.C.10    Veyrac, M.11    Chamouard, P.12    Humbel, R.L.13
  • 137
    • 0031718221 scopus 로고    scopus 로고
    • Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn’s disease
    • Arai, F; Takahashi, T; Furukawa, K; Matsushima, K; Asakura, H. Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and in Crohn’s disease. Dig Dis Sci, 1998, 43, 2071-2079.
    • (1998) Dig Dis Sci , vol.43 , pp. 2071-2079
    • Arai, F.1    Takahashi, T.2    Furukawa, K.3    Matsushima, K.4    Asakura, H.5
  • 138
    • 0032014268 scopus 로고    scopus 로고
    • Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis
    • Anezaki, K; Asakura, H; Honma, T; Ishizuka, K; Funakoshi, K; Tsukada, Y; Narisawa, R. Correlations between interleukin-8, and myeloperoxidase or luminol-dependent chemiluminescence in inflamed mucosa of ulcerative colitis. Intern Med, 1998, 37, 253-258.
    • (1998) Intern Med , vol.37 , pp. 253-258
    • Anezaki, K.1    Asakura, H.2    Honma, T.3    Ishizuka, K.4    Funakoshi, K.5    Tsukada, Y.6    Narisawa, R.7
  • 142
    • 33744812402 scopus 로고    scopus 로고
    • Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-delta pathway activation
    • Song, J; Li, J; Lulla, A; Evers, BM; Chung, DH. Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/PKC-delta pathway activation. Am J Physiol Cell Physiol, 2006, 290, C1469-C1476.
    • (2006) Am J Physiol Cell Physiol , vol.290 , pp. C1469-C1476
    • Song, J.1    Li, J.2    Lulla, A.3    Evers, B.M.4    Chung, D.H.5
  • 143
    • 34249805957 scopus 로고    scopus 로고
    • Lecithinized superoxide dismutase was effective for ulcerative colitis
    • Mizushima, T. Lecithinized superoxide dismutase was effective for ulcerative colitis. Inflam Regen, 2006, 26, 317.
    • (2006) Inflam Regen , vol.26 , pp. 317
    • Mizushima, T.1
  • 145
    • 0141534421 scopus 로고    scopus 로고
    • Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients
    • Danese, S; Katz, JA; Saibeni, S; Papa, A; Gasbarrini, A; Vecchi, M; Fiocchi, C. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut, 2003, 52, 1435-1441.
    • (2003) Gut , vol.52 , pp. 1435-1441
    • Danese, S.1    Katz, J.A.2    Saibeni, S.3    Papa, A.4    Gasbarrini, A.5    Vecchi, M.6    Fiocchi, C.7
  • 148
    • 20444473689 scopus 로고    scopus 로고
    • A regenerative role for bone marrow following experimental colitis: Contribution to neovasculogenesis and myofibroblasts
    • Brittan, M; Chance, V; Elia, G; Poulsom, R; Alison, MR; MacDonald, TT; Wright, NA. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology, 2005, 128, 1984-1995.
    • (2005) Gastroenterology , vol.128 , pp. 1984-1995
    • Brittan, M.1    Chance, V.2    Elia, G.3    Poulsom, R.4    Alison, M.R.5    MacDonald, T.T.6    Wright, N.A.7
  • 149
    • 0031889085 scopus 로고    scopus 로고
    • Course of Crohn’s disease after allogeneic marrow transplantation
    • Lopez-Cubero, SO; Sullivan, KM; McDonald, GB. Course of Crohn’s disease after allogeneic marrow transplantation. Gastroenterology, 1998, 114, 433-440.
    • (1998) Gastroenterology , vol.114 , pp. 433-440
    • Lopez-Cubero, S.O.1    Sullivan, K.M.2    McDonald, G.B.3
  • 150
    • 38549087476 scopus 로고    scopus 로고
    • Innate immunity in inflammatory bowel disease: A disease hypothesis
    • Marks, DJB; Segal, AW. Innate immunity in inflammatory bowel disease: a disease hypothesis. J Pathol, 2008, 214, 260-266.
    • (2008) J Pathol , vol.214 , pp. 260-266
    • Marks, D.J.B.1    Segal, A.W.2
  • 151
    • 34548156973 scopus 로고    scopus 로고
    • Late-Breaking News from the-4th International Meeting on Inflammatory Bowel Diseases Capri, 2006
    • Latella, G; Fiocchi, C; Caprilli, R. Late-Breaking News from the-4th International Meeting on Inflammatory Bowel Diseases Capri, 2006. Inflamm Bowel Dis, 2007, 13, 1031-1050.
    • (2007) Inflamm Bowel Dis , vol.13 , pp. 1031-1050
    • Latella, G.1    Fiocchi, C.2    Caprilli, R.3
  • 152
    • 33751549013 scopus 로고    scopus 로고
    • Suppression of experimental colitis by intestinal mononuclear phagocytes
    • Qualls, JE; Kaplan, AM; van Rooijen, N; Cohen, DA. Suppression of experimental colitis by intestinal mononuclear phagocytes. J Leukocyte Biol, 2006, 80, 802-815.
    • (2006) J Leukocyte Biol , vol.80 , pp. 802-815
    • Qualls, J.E.1    Kaplan, A.M.2    van Rooijen, N.3    Cohen, D.A.4
  • 153
    • 35648937573 scopus 로고    scopus 로고
    • Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease
    • Kawada, M; Arihiro, A; Mizoguchi, E. Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol, 2007, 13, 5581-5593.
    • (2007) World J Gastroenterol , vol.13 , pp. 5581-5593
    • Kawada, M.1    Arihiro, A.2    Mizoguchi, E.3
  • 154
    • 35649000421 scopus 로고    scopus 로고
    • Role of bacteria in the etiopathogenesis of inflammatory bowel disease
    • Barnich, N; Darfeuilli-Michaud, A. Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol, 2007, 13, 5571-5576.
    • (2007) World J Gastroenterol , vol.13 , pp. 5571-5576
    • Barnich, N.1    Darfeuilli-Michaud, A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.